Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Large Pharma

Bristol-Myers Squibb Co

+ Add to Watchlist

BRM:GR

61.513 EUR 0.541 0.87%

As of 02:01:43 ET on 05/27/2015.

Snapshot for Bristol-Myers Squibb Co (BRM)

Open: 62.248 Day's Range: 61.513 - 62.815 Volume: 245
Previous Close: 62.054 52wk Range: 34.115 - 64.591 1-Yr Rtn: +76.16%

Stock Chart for BRM

No chart data available.
  • BRM:GR 62.050
  • 1D
  • 1M
  • 1Y
62.054
Interactive BRM Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BRM

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) 39.1022
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2015) 1.7530
Est. PEG Ratio 2.3206
Market Cap (M EUR) 104,686.00
Shares Outstanding (M) 1,666.98
30 Day Average Volume 3,875
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 2.19%
Cash Dividend (USD) 0.3700
Dividend Ex-Date 04/01/2015
5 Year Dividend Growth 6.04%
Next Earnings Announcement 07/24/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BRM

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for BRM

Bristol-Myers Squibb Company is a global biopharmaceutical company. The Company develops, licenses, manufactures, markets, and sells pharmaceutical and nutritional products. Bristol-Myers Squibb products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection, and psychiatric disorders.

Lamberto AndreottiChairmanGiovanni CaforioChief Executive Officer
Louis S SchmuklerPres:Global Manufacturing & SupplyCharles A BancroftExec VP/CFO
More Company Profile & Key Executives for BRM

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil